Hyperhidrosis, characterized by excess sweat production, affects children and adults. Primary focal hyperhidrosis affects any anatomic region with sweat appendages present. Primary hyperhidrosis has traditionally been considered a problem for adults, but approximately 1.6% of adolescents and 0.6% of prepubertal children are affected. Psychological and social development and well-being are often affected, leading to profound emotional and social distress. Quality of life can be improved by early diagnosis and therapy; however, underdiagnosis and lack of knowledge regarding therapeutic options has hindered optimization of therapy in the pediatric population. This article reviews the treatment options for hyperhidrosis with a focus on the pediatric population.
Key points
- •
Primary hyperhidrosis has traditionally been considered a medical and psychosocial problem for adult patients, with estimates suggesting that 1.6% of adolescents and 0.6% of prepubertal children are affected by this condition.
- •
A thorough history and physical examination should be performed to help rule out an underlying causation for secondary hyperhidrosis before initiating treatment.
- •
Quality of life in the pediatric population can be significantly improved by early diagnosis and therapy.
- •
Many therapeutic options for primary pediatric hyperhidrosis exist including topical and systemic therapies, iontophoresis, and botulinum toxin injections.
Related posts:
Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree
